Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35E3 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc35e3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC35E3 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of SLC35E3 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Slc35e3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC35E3 mRNA | CTD | PMID:17942748 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32679240 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slc35e3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC35E3 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC35E3 mRNA | CTD | PMID:28922406 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC35E3 mRNA | CTD | PMID:21570461 more ... | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC35E3 mRNA | CTD | PMID:22574217 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SLC35E3 mRNA | CTD | PMID:26251327 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Slc35e3 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of SLC35E3 promoter | CTD | PMID:33297965 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of SLC35E3 protein | CTD | PMID:20106945 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SLC35E3 mRNA | CTD | PMID:33167477 | benzo[a]pyrene | increases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLC35E3 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SLC35E3 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of SLC35E3 mRNA | CTD | PMID:21632981 | bisphenol A | affects expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SLC35E3 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SLC35E3 mRNA | CTD | PMID:33221593 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of SLC35E3 mRNA | CTD | PMID:26079696 | chlorpyrifos | decreases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SLC35E3 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of SLC35E3 mRNA | CTD | PMID:19561079 and PMID:27392435 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SLC35E3 mRNA | CTD | PMID:27392435 | coumarin | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | coumarin results in increased expression of SLC35E3 mRNA | CTD | PMID:18480146 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of SLC35E3 mRNA | CTD | PMID:25562108 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SLC35E3 mRNA | CTD | PMID:29803840 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of SLC35E3 mRNA | CTD | PMID:23649840 | fenthion | decreases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Fenthion results in decreased expression of SLC35E3 mRNA | CTD | PMID:34813904 | flutamide | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of SLC35E3 mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SLC35E3 mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of SLC35E3 mRNA | CTD | PMID:23649840 | gentamycin | decreases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC35E3 mRNA | CTD | PMID:33387578 | indole-3-methanol | multiple interactions | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC35E3 mRNA | CTD | PMID:22129741 | inulin | multiple interactions | ISO | Slc35e3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC35E3 mRNA | CTD | PMID:36331819 | ketamine | decreases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of SLC35E3 mRNA | CTD | PMID:20080153 | leflunomide | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | leflunomide results in increased expression of SLC35E3 mRNA | CTD | PMID:24136188 | methidathion | decreases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | methidathion results in decreased expression of SLC35E3 mRNA | CTD | PMID:34813904 | N,N-diethyl-m-toluamide | multiple interactions | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of SLC35E3 gene | CTD | PMID:33148267 | N-nitrosodiethylamine | multiple interactions | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SLC35E3 mRNA | CTD | PMID:22129741 | nefazodone | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | nefazodone results in increased expression of SLC35E3 mRNA | CTD | PMID:24136188 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of SLC35E3 mRNA | CTD | PMID:24768652 | nimesulide | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | nimesulide results in increased expression of SLC35E3 mRNA | CTD | PMID:24136188 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SLC35E3 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SLC35E3 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc35e3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC35E3 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC35E3 mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of SLC35E3 mRNA | CTD | PMID:36326898 | permethrin | multiple interactions | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of SLC35E3 gene | CTD | PMID:33148267 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC35E3 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of SLC35E3 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of SLC35E3 mRNA | CTD | PMID:28903501 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SLC35E3 mRNA | CTD | PMID:23557933 | rotenone | increases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Rotenone results in increased expression of SLC35E3 mRNA | CTD | PMID:32937126 | tetrachloromethane | multiple interactions | ISO | Slc35e3 (Mus musculus) | 6480464 | [PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of SLC35E3 mRNA | CTD | PMID:29987408 | thioacetamide | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SLC35E3 mRNA | CTD | PMID:23411599 | thioacetamide | decreases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of SLC35E3 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SLC35E3 mRNA | CTD | PMID:27760801 | triphenyl phosphate | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | triphenyl phosphate results in increased expression of SLC35E3 mRNA | CTD | PMID:30589522 | trovafloxacin | decreases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | trovafloxacin results in decreased expression of SLC35E3 mRNA | CTD | PMID:24136188 | valdecoxib | increases expression | ISO | Slc35e3 (Rattus norvegicus) | 6480464 | valdecoxib results in increased expression of SLC35E3 mRNA | CTD | PMID:24136188 | valproic acid | affects expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SLC35E3 mRNA | CTD | PMID:17292431 | valproic acid | increases expression | ISO | Slc35e3 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of SLC35E3 mRNA | CTD | PMID:20546886 and PMID:21427059 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLC35E3 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SLC35E3 mRNA | CTD | PMID:25979313 | |